If you are demanding any product or service please register as Farmavita.Net network member and publish your offer or demad. In-Licensing and oursoucing of products is usual a way for development of winning portfolio of products. License-in is also very cost effective way of product/technology development. Opportunities are listed according chronological order, the most recent first.

Africa - demand for anti-retrovirals and anti-tuberculosis

Popular Wanted

Description

Start-up pharmaceutical tuberculosiscompany from South Africa is looking for  Dossier and contract manufacturing of  anti-retrovirals and antitubersulosis. 

Since they are a start up pharmaceutical company their ‘foot in the door strategy’ is to start with ARVs (ant retro viral) and Anti-TB medicines. They would like to know if anyone  can assist them with the following licences / dossiers:

  • TDF Tenofovir Disoproxil Fumarate (300) + FTC Emtricitabine (200) + EFV Efavirenz (400)
  • TAF Tenofovir alafenamide (300) + DOL Dolutegravir ( 50mg ) + 3TC Lamivudine (300)
  •  EVG Elvitegravir (85mg ) + COBI Cobicistat (150mg) + FTC Emtricitabine ( 200mg) + TAF Tenofovir alafenamide fumarate (25mg)
  •  FTC Emtricitabine (200) + TAF Tenofovir alafenamide (300)

For more details, please contact us at info@famavitar.com 

More details

Name Description
Pharma licensing In-licensing (demand)

Ad details

Ad ID : 939

Advertiser details

00385 1 3377058
Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
619 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
528 Views
Profitable and Modern Russian CMO with long...
499 Views
Adalimumab API available: - from EU cGMP...
10240 Views
Infliximab API available: - from EU cGMP...
519 Views
Normal 0 false false false EN-US X-NONE HE /*...
507 Views
Start-up pharmaceutical company from South...
1913 Views